RU2016121001A3 - - Google Patents
Download PDFInfo
- Publication number
- RU2016121001A3 RU2016121001A3 RU2016121001A RU2016121001A RU2016121001A3 RU 2016121001 A3 RU2016121001 A3 RU 2016121001A3 RU 2016121001 A RU2016121001 A RU 2016121001A RU 2016121001 A RU2016121001 A RU 2016121001A RU 2016121001 A3 RU2016121001 A3 RU 2016121001A3
- Authority
- RU
- Russia
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Inorganic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Endocrinology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2014120626 | 2014-05-22 | ||
RU2014120626/15A RU2014120626A (ru) | 2014-05-22 | 2014-05-22 | Инсулинсодержащий препарат пролонгированного действия |
PCT/RU2015/000317 WO2015178806A1 (ru) | 2014-05-22 | 2015-05-19 | Инсулинсодержащий препарат пролонгированного действия |
Publications (3)
Publication Number | Publication Date |
---|---|
RU2016121001A RU2016121001A (ru) | 2018-06-22 |
RU2016121001A3 true RU2016121001A3 (de) | 2018-06-22 |
RU2676101C2 RU2676101C2 (ru) | 2018-12-26 |
Family
ID=54554358
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2014120626/15A RU2014120626A (ru) | 2014-05-22 | 2014-05-22 | Инсулинсодержащий препарат пролонгированного действия |
RU2016121001A RU2676101C2 (ru) | 2014-05-22 | 2015-05-19 | Инсулинсодержащий препарат пролонгированного действия |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2014120626/15A RU2014120626A (ru) | 2014-05-22 | 2014-05-22 | Инсулинсодержащий препарат пролонгированного действия |
Country Status (6)
Country | Link |
---|---|
US (1) | US20170136096A1 (de) |
EP (1) | EP3254688A4 (de) |
CN (1) | CN106794226A (de) |
HK (1) | HK1248118A1 (de) |
RU (2) | RU2014120626A (de) |
WO (1) | WO2015178806A1 (de) |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4908350A (en) * | 1985-10-31 | 1990-03-13 | The Regents Of The University Of California | Hyperosmotic/hyperoncotic solutions for resuscitation of hypodynamic shock |
JPH01287041A (ja) * | 1988-05-13 | 1989-11-17 | Rooman Kogyo:Kk | 徐放性製剤 |
GB2237510B (en) * | 1989-11-04 | 1993-09-15 | Danbiosyst Uk | Small particle drug compositions for nasal administration |
US5416071A (en) * | 1991-03-12 | 1995-05-16 | Takeda Chemical Industries, Ltd. | Water-soluble composition for sustained-release containing epo and hyaluronic acid |
US6284727B1 (en) * | 1993-04-07 | 2001-09-04 | Scios, Inc. | Prolonged delivery of peptides |
US7303768B2 (en) * | 1998-07-24 | 2007-12-04 | Seo Hong Yoo | Preparation of aqueous clear solution dosage forms with bile acids |
SE9904121D0 (sv) * | 1999-11-15 | 1999-11-15 | Gustaf Jederstroem | Hydrophobe biomolecular structure |
EP1296660A4 (de) * | 2000-06-27 | 2005-04-13 | Mi Tech Company Ltd | Zubereitung zur kontrollierten freisetzung von insulin und deren herstellungsmethode |
FR2822834B1 (fr) * | 2001-04-02 | 2005-02-25 | Flamel Tech Sa | Suspension colloidale de nanoparticules a base de copolymeres amphiphile pour la vectorisation de principes actifs et leur mode de preparation |
WO2003053460A1 (en) * | 2001-12-19 | 2003-07-03 | Eli Lilly And Company | Crystalline compositions for controlling blood glucose |
US20040005999A1 (en) * | 2002-03-07 | 2004-01-08 | Andreasen Kasper Huus | Polyamino acid-based particle insulin preparation |
US20030211976A1 (en) * | 2002-03-07 | 2003-11-13 | Andreasen Kasper Huus | Polyamino acid-based particle insulin formulation |
CA2518136A1 (en) * | 2003-03-04 | 2004-09-16 | The Technology Development Company Ltd. | Oral insulin composition and methods of making and using thereof |
AU2005291233B2 (en) * | 2004-10-05 | 2011-02-03 | Novo Nordisk A/S | A pharmaceutical formulation comprising crystalline insulin and dissolved insulin |
US8679540B2 (en) * | 2006-06-09 | 2014-03-25 | Flamel Technologies | Pharmaceutical formulations for the prolonged release of active principle(s), and their applications, especially therapeutic applications |
EP2017288A1 (de) * | 2007-07-16 | 2009-01-21 | Novo Nordisk A/S | Proteasestabilisierte pegylierte Insulinanaloga |
US20110189299A1 (en) * | 2008-07-01 | 2011-08-04 | Nitto Denko Corporation | Pharmaceutical composition containing surface-coated microparticles |
EA013569B1 (ru) * | 2009-02-24 | 2010-06-30 | Ооо "Научно-Производственный Комплекс "Наносистема"" | Фармацевтическая композиция рифабутина для лечения туберкулеза и заболеваний, опосредованных helicobacter pylori, способ ее получения и способ лечения |
US20120094902A1 (en) * | 2009-03-27 | 2012-04-19 | Adocia | Fast-acting insulin formulation |
CN102397535B (zh) * | 2010-09-15 | 2013-08-28 | 中国科学院生物物理研究所 | 胰岛素结晶微球、其混悬剂、以及制备方法 |
-
2014
- 2014-05-22 RU RU2014120626/15A patent/RU2014120626A/ru unknown
-
2015
- 2015-05-19 EP EP15795367.0A patent/EP3254688A4/de not_active Withdrawn
- 2015-05-19 US US15/313,356 patent/US20170136096A1/en not_active Abandoned
- 2015-05-19 RU RU2016121001A patent/RU2676101C2/ru active
- 2015-05-19 HK HK18107670.2A patent/HK1248118A1/en unknown
- 2015-05-19 CN CN201580039533.3A patent/CN106794226A/zh active Pending
- 2015-05-19 WO PCT/RU2015/000317 patent/WO2015178806A1/ru active Application Filing
Also Published As
Publication number | Publication date |
---|---|
EP3254688A4 (de) | 2018-03-14 |
WO2015178806A1 (ru) | 2015-11-26 |
EP3254688A1 (de) | 2017-12-13 |
US20170136096A1 (en) | 2017-05-18 |
RU2016121001A (ru) | 2018-06-22 |
CN106794226A (zh) | 2017-05-31 |
RU2014120626A (ru) | 2015-11-27 |
RU2676101C2 (ru) | 2018-12-26 |
HK1248118A1 (en) | 2018-10-12 |
Similar Documents
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC41 | Official registration of the transfer of exclusive right |
Effective date: 20190424 |